|
|
Jumpstarting the Transformation to True Personalized Medicine: Potential Catalysts and KeystonesPublished by: IDC Published: Aug. 9, 2007 - 19 Pages Table of ContentsTable of Contents Health Industry Insights Opinion In This Report Brief Description of the Solution Situation Overview Current Environment Table: Cardiovascular Adverse Events for Selected Drugs Management Challenges Emerging Process Keystones and Other Supporting Knowledge Infrastructure The $1,000 Genome Whole Genome Sequences from Individuals Advances in Systems Biology Advances in Translational Medicine Potential Catalysts to Accelerate Personalized Medicine Adoption Large-Scale Genotyping of Clinical Trial Participants Routine Post?Clinical Trial Genotyping for All Adverse Event Patients Development of Minable EHRs Containing Whole Genome Data for Adverse Event Patients Biobanking of Adverse Event Tissues Strategic Efforts to Watch Success Factors Factors Affecting Adoption Future Outlook Remaining Challenges Market Trends Potential Pitfalls Essential Guidance Actions to Consider Pharma Healthcare Providers Healthcare Payers Patient Advocacy Groups Learn More Related Research Synopsis AbstractThis document is about Jumpstarting the Transformation to True Personalized Medicine: Potential Catalysts and KeystonesGet Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||